1990MO Sacituzumab govitecan (SG) as second-line (2L) treatment for extensive stage small cell lung cancer (ES-SCLC): Preliminary results from the phase II TROPiCS-03 basket trial
- Resource Type
- Abstract
- Source
- In
Annals of Oncology October 2023 34 Supplement 2:S1061-S1062 - Subject
- Language
- ISSN
- 0923-7534